BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26095781)

  • 41. Cost savings from palliative care teams and guidance for a financially viable palliative care program.
    McCarthy IM; Robinson C; Huq S; Philastre M; Fine RL
    Health Serv Res; 2015 Feb; 50(1):217-36. PubMed ID: 25040226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic impact of hospitalisations among patients in the last year of life: an observational study.
    Gardiner C; Ward S; Gott M; Ingleton C
    Palliat Med; 2014 May; 28(5):422-9. PubMed ID: 24367059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sources of referral, costs and length of hospital stay in a teaching hospital: impact of a day care facility.
    FitzGerald GA; Beggan M; Drury MI
    Ir Med J; 1981 Sep; 74(9):265-70. PubMed ID: 7287391
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hospital processes and costs in neurology. A study of a referral hospital].
    Canto-TorĂ¡n E; Vivas-Consuelo D; Barrachina-Martinez I; Escudero-Torrella J
    Rev Neurol; 2011 Nov; 53(10):599-606. PubMed ID: 22052175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Palliative care in an acute care hospital: from pilot to consultation service.
    Rice EM; Betcher DK
    Medsurg Nurs; 2010; 19(2):107-12. PubMed ID: 20476521
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute hospital costs after minimally invasive versus open lumbar interbody fusion: data from a US national database with 6106 patients.
    Wang MY; Lerner J; Lesko J; McGirt MJ
    J Spinal Disord Tech; 2012 Aug; 25(6):324-8. PubMed ID: 21685806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital-based palliative care: cost-effective care for patients with advanced disease.
    Stephens S
    J Nurs Adm; 2008 Mar; 38(3):143-5. PubMed ID: 18327063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The health economics of palliative care.
    Payne SK; Coyne P; Smith TJ
    Oncology (Williston Park); 2002 Jun; 16(6):801-8; discussion 808, 811-2. PubMed ID: 12088300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Costs of hospitalisation for exacerbations of COPD in patients receiving domiciliary rehabilitation].
    Romain D; Bernady A; Etchamendy E; Barokas T; Pignede P
    Rev Mal Respir; 2011 Sep; 28(7):864-72. PubMed ID: 21943531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients.
    Bradley CJ; Dahman B; Bear HD
    Cancer; 2012 Oct; 118(20):5084-91. PubMed ID: 22415708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
    Genther DJ; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics associated with higher cost per day or longer length of stay in hospitalized patients who died during the hospitalization or were discharged to hospice.
    Youngwerth JM; Bartley JB; Yamashita TE; Kutner JS
    J Hosp Med; 2011; 6(6):338-43. PubMed ID: 21834115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study: palliative care cuts hospitalization costs.
    Healthcare Benchmarks Qual Improv; 2011 May; 18(5):52-3. PubMed ID: 21608318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hospitalization costs for radical prostatectomy attributable to robotic surgery.
    Kim SP; Shah ND; Karnes RJ; Weight CJ; Shippee ND; Han LC; Boorjian SA; Smaldone MC; Frank I; Gettman MT; Tollefson MK; Thompson RH
    Eur Urol; 2013 Jul; 64(1):11-6. PubMed ID: 22959352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of a New Palliative Care Program on Health System Finances: An Analysis of the Palliative Care Program Inpatient Unit and Consultations at Johns Hopkins Medical Institutions.
    Isenberg SR; Lu C; McQuade J; Chan KKW; Gill N; Cardamone M; Torto D; Langbaum T; Razzak R; Smith TJ
    J Oncol Pract; 2017 May; 13(5):e421-e430. PubMed ID: 28245147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Palliative Care Consultation Lowers Hospital Costs.
    McBride D
    ONS Connect; 2015 Dec; 30(4):14-5. PubMed ID: 26753421
    [No Abstract]   [Full Text] [Related]  

  • 58. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Palliative care: an example of Comparative Effectiveness Research?].
    Schmacke N
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):484-91. PubMed ID: 22981024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF; Chiong JR; Christian R; Lin J
    Hosp Pract (1995); 2012 Feb; 40(1):7-14. PubMed ID: 22406878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.